Aier Eye Hospital Group (300015)
Shenzhen Stock Exchange · China · prices in CNY · close of 20 Oct 2026
Key indicators
| Last close | CNY 7.940 |
|---|---|
| 52-week range | 7.670 – 12.601 |
| Return, 1 month / 3 months | −1.5% / −9.6% |
| Return, 1 year / 3 years | −34.5% / −54.6% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 27.2% |
| Worst drawdown (1 year) | -38.0% |
| Average daily value traded | 522.94M CNY |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aier Eye Hospital Group runs a network of private eye hospitals and clinics in China, offering ophthalmic care to patients. Its services include surgery for cataracts, laser correction of vision, and treatment of retinal and other eye conditions, along with routine eye examinations and related procedures. The group is based in Changsha, in Hunan province, and serves patients through its own facilities rather than through public hospitals.
Aier Eye Hospital Group trades under the code 300015 on the Shenzhen Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aier Eye Hospital Group (300015) trades on the Shenzhen Stock Exchange in China. It last closed at CNY 7.940 on 20 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 785 of 2,821 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 34.5% and over the last three months it fell 9.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shenzhen Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.6% | ||
| From 52-week high | -36.7% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -9.6% | ||
| 6-month return | -16.5% | ||
| 12-month return, skipping the last month | -33.6% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.0% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 522.94M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | −1.5% |
| 3 months | −9.6% |
| 6 months | −16.5% |
| 1 year | −34.5% |
| 3 years | −54.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 8.270 / 9.405 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.143 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jul 2026 | CNY 0.1000 |
| 15 Jan 2026 | CNY 0.0800 |
| 11 Jun 2025 | CNY 0.1600 |
| 6 Jun 2024 | CNY 0.1500 |
| 8 Jun 2023 | CNY 0.1300 |
| 11 Jul 2022 | CNY 0.1555 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shenzhen Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.